Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Alemtuzumab in multiple sclerosis: an update.
Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings.
Effective management of intractable neuropathic pain using an intrathecal morphine pump in a patient with acute transverse myelitis.
[Charcot-Marie-Tooth disease associated with periaxin mutations (CMT4F): Clinical, electrophysiological and genetic analysis of 24 patients.]
Comparison between Trans-Cranial Electromagnetic Stimulation and Low-Level Laser on Modulation of Trigeminal Neuralgia.
[Clinical epidemiology of multiple sclerosis in Moscow. Discriptive epidemiology in population of one region of Moscow.]
Step-rate thresholds for physical activity intensity in persons with multiple sclerosis.
Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.
How to run a multiple sclerosis relapse clinic.
Literature Commentary.
Effects of whole body vibration on hormonal & functional indices in patients with multiple sclerosis.
Multiple sclerosis in men: management considerations.
Analysis of miRNA in Normal Appearing White Matter to Identify Altered CNS Pathways in Multiple Sclerosis.
Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.
MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.
The Association of Depression with Pain-Related Treatment Utilization in Patients with Multiple Sclerosis.
Vitamin D as a protective factor in multiple sclerosis.
Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.
The Immune Pathogenesis of Multiple Sclerosis.
Relationship between Damage to the Cerebellar Peduncles and Clinical Disability in Multiple Sclerosis.
Bringing CLARITY to gray matter atrophy.
Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method.
Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase.
Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: The role of kallikrein-kinin system.
Investigation of cytocrom c oxidase gene subunits expression on the Multiple sclerosis.
Pages
« first
‹ previous
…
420
421
422
423
424
425
426
427
428
…
next ›
last »